Search filters

List of works by Oliver Floßmann

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.

scientific article published on 13 December 2010

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

scientific article published in April 2011

Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

scientific article published on 01 October 2012

Clinical and biological assessment in systemic necrotizing vasculitides.

scientific article published on March 2006

Clinical management of anaemia pre-endstage renal failure

scientific article published on November 2003

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

scientific article

Explaining fatigue in ANCA-associated vasculitis.

scientific article published on 4 June 2013

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

scientific article

Gusperimus: immunological mechanism and clinical applications.

scientific article published on 05 February 2014

Long-term damage to the ENT system in Wegener's granulomatosis.

scientific article

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis

scientific article

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

scientific article published on 24 April 2013

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.

scientific article

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

scientific article published on 03 December 2008

Outcome in small-vessel systemic vasculitis

scientific article published on 01 July 2006

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

scientific article published on 01 February 2020

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

scientific article published on November 2006

Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.

scientific article

Reply: To PMID 22614882

scientific article published on 01 March 2013

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

scientific article published on 01 February 2012

Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis

scientific article published on 23 May 2015

The characterisation and determinants of quality of life in ANCA associated vasculitis.

scientific article

The future of damage assessment in vasculitis.

scientific article published on June 2007

The long-term outcomes of systemic vasculitis.

scientific article

The role of biologic therapies in the management of systemic vasculitis.

scientific article published on 20 February 2006

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.

scientific article published on 23 September 2016

When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?

scientific article published on 01 May 2007

Paulina is supported by:

About Paulina

Help